Skip to content

JNJ

JOHNSON & JOHNSON

NYSE · Healthcare · Drug Manufacturers - General · US

$266.17
−1.62%
Ask drillr
Price chart
Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29Nov 3
Key dataNov 3, 2026
Open
$268.51
From 52W high
−4.40%
Volume
6.47M
Market cap
$640.75B
P/E (Fwd)
23.6x
EV/EBITDA
21.7x
P/E (TTM)
40.4x
RSI (14)
54.8
1D Return
−1.62%
YTD Return
+29.93%
SummaryUpdated Sep 1, 2026

Johnson & Johnson (NYSE:JNJ) is one of the world's largest and most diversified healthcare companies, founded in 1886 by the Johnson brothers in New Brunswick, New Jersey. Originally starting as a manufacturer of ready-to-use sterile surgical dressings, the company has evolved over nearly 140 years into a global healthcare conglomerate. Today, J&J operates as a two-sector company focused on <b>Innovative Medicine</b> (pharmaceuticals) and <b>MedTech</b> (medical devices), having completed the spin-off of its Consumer Health division (Kenvue) in 2023. The company serves patients, healthcare professionals, and consumers across more than 175 countries worldwide, maintaining its position as a healthcare industry leader through continuous innovation and strategic acquisitions.

Similar companies

Latest newsMore news →